UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$188M |
| 2 |
Yelp
YELP
|
+$182M |
| 3 |
General Motors
GM
|
+$141M |
| 4 |
American Express
AXP
|
+$138M |
| 5 |
Comcast
CMCSA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$331M |
| 2 |
Crown Castle
CCI
|
+$303M |
| 3 |
Cardinal Health
CAH
|
+$204M |
| 4 |
Gilead Sciences
GILD
|
+$157M |
| 5 |
Apple
AAPL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.6% |
| 2 | Healthcare | 13.9% |
| 3 | Technology | 13.4% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
New York Times
NYT
$10.5B
| $1.1M | ﹤0.01% |
69,395
-7,300
| -10% | -$99.3K |
|
1427
Prospect Capital
PSEC
$1.11B
| $1.1M | ﹤0.01% |
97,851
-11,695
| -11% | -$132K |
|
1428
Tyler Technologies
TYL
$12.5B
| $1.09M | ﹤0.01% |
10,699
-400
| -4% | -$38.9K |
|
1429
Portland General Electric
POR
$5.71B
| $1.09M | ﹤0.01% |
36,098
-27,190
| -43% | -$799K |
|
1430
Casey's General Stores
CASY
$30.8B
| $1.09M | ﹤0.01% |
15,499
+300
| +2% | +$22K |
|
|
UNS
1431
DELISTED
UNS ENERGY CORP COM
UNS
| $1.09M | ﹤0.01% |
18,199
+3,300
| +22% | +$166K |
|
1432
Sabra Healthcare REIT
SBRA
$5.34B
| $1.09M | ﹤0.01% |
41,606
+2,300
| +6% | +$59.3K |
|
1433
MGIC Investment
MTG
$6.21B
| $1.09M | ﹤0.01% |
128,889
-10,900
| -8% | -$87K |
|
|
VPHM
1434
DELISTED
VIROPHARMA INC
VPHM
| $1.09M | ﹤0.01% |
21,798
-226,485
| -91% | -$10.1M |
|
1435
Primerica
PRI
$10.2B
| $1.08M | ﹤0.01% |
25,198
-3,400
| -12% | -$144K |
|
|
CADE
1436
DELISTED
Cadence Bank
CADE
| $1.08M | ﹤0.01% |
42,497
-4,700
| -10% | -$107K |
|
|
CVA
1437
DELISTED
Covanta Holding Corporation
CVA
| $1.08M | ﹤0.01% |
60,836
-5,900
| -9% | -$109K |
|
|
TMH
1438
DELISTED
Team Health Holdings Inc
TMH
| $1.08M | ﹤0.01% |
23,698
-6,300
| -21% | -$280K |
|
1439
Archrock
AROC
$5.84B
| $1.08M | ﹤0.01% |
31,498
-5,500
| -15% | -$170K |
|
1440
iShares MBS ETF
MBB
$39B
| – | – |
0
| – | – |
|
1441
Karyopharm Therapeutics
KPTI
$44.2M
| $1.07M | ﹤0.01% |
+3,120
| New | +$862K |
|
1442
Voya Financial
VOYA
$9.2B
| $1.07M | ﹤0.01% |
30,400
+23,100
| +316% | +$762K |
|
1443
Avient
AVNT
$3.91B
| $1.07M | ﹤0.01% |
30,197
-2,000
| -6% | -$63.7K |
|
1444
Viasat
VSAT
$11.3B
| $1.06M | ﹤0.01% |
16,999
+100
| +0.6% | +$6.3K |
|
|
TIVO
1445
DELISTED
Tivo Inc
TIVO
| $1.06M | ﹤0.01% |
53,954
-6,200
| -10% | -$113K |
|
1446
Nuwellis
NUWE
$594K
| – | – |
0
| – | – |
|
1447
TD Synnex
SNX
$20.7B
| $1.06M | ﹤0.01% |
31,398
+2,800
| +10% | +$89.1K |
|
1448
Rollins
ROL
$17.7B
| $1.06M | ﹤0.01% |
117,781
-4,050
| -3% | -$33.7K |
|
1449
STAG Industrial
STAG
$7.1B
| $1.06M | ﹤0.01% |
51,790
+1,200
| +2% | +$25K |
|
1450
Minerals Technologies
MTX
$2.34B
| $1.04M | ﹤0.01% |
17,399
+3,500
| +25% | +$198K |
|
Similar funds
UBS AM's Q4 2013 Portfolio in Review
As of Q4 2013, UBS AM held 2,637 positions worth $87.5B, up 8.1% from $80.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2013 filing shows 130 new, 1,010 increased, 1,128 reduced and 103 closed positions. Its largest new stake was Trip.com Group: 2,309,000 shares worth $57.3M. The largest sale was eBay, an estimated $331M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- UBS AM's largest Q4 2013 buy was Trip.com Group: 2,309,000 shares worth $57.3M.
- UBS AM added most to Regeneron Pharmaceuticals in Q4 2013, an estimated $188M increase.
- UBS AM's biggest Q4 2013 reduction was eBay, cutting an estimated $331M.
- UBS AM fully exited DELL INC in Q4 2013, selling an estimated $62.9M.
- UBS AM's ten largest holdings make up 14% of its $87.5B portfolio in Q4 2013.
- UBS AM opened 130 new positions and closed 103 in Q4 2013.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $87.5B.
Based on UBS AM's 13F filing for Q4 2013, filed 31 Jan 2014.